Mather Group
ORKA icon

Mather Group’s Oruka Therapeutics ORKA Stock Holding History

Mather Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.67K Buy
+20
New +$1.88K ﹤0.01% 2085

Other funds holding ORKA

Secure Asset Management
Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Mather Group's ORKA Position: Q3 2026 in Review

Mather Group opened a new position in Oruka Therapeutics (ORKA) in Q3 2026: 20 shares worth $1.67K. The stake represents ﹤0.01% of the portfolio and ranks #2085 among its holdings.

10 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • Mather Group held 20 shares of Oruka Therapeutics worth $1.67K as of Q3 2026.
  • Oruka Therapeutics was a new Mather Group position in Q3 2026.
  • Oruka Therapeutics made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #2085 holding.
  • 10 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.